Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Finn

Showing results (161-170 of 235) with videos related to

Pageof 24
Sort By:
Vaccine|December 5, 2016
Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trialMildred A Iro, Matthew D Snape, Merryn Voysey, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 18, 2017
Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedulesManish Sadarangani, Tim Sell, Mildred A Iro, et al.
Vaccine|May 10, 2017
Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]Mildred A Iro, Matthew D Snape, Merryn Voysey, et al.
Vaccine|July 14, 2020
Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant seriesJennifer L Oliver, Christine Sadorge, Florence Boisnard, et al.
BMJ Open|October 23, 2020
'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescentsJeremy Carr, Emma Plested, Parvinder Aley, et al.
The Pediatric Infectious Disease Journal|July 2, 2019
Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire StudyChristopher R Wilcox, Anna Calvert, Jane Metz, et al.
BMJ Open|May 9, 2019
B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of <i>Neisseria meningitidis</i>Helen S Marshall, Mark McMillan, Ann Koehler, et al.
Vaccine|April 5, 2024
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trialHolly E Baum, Russell Thirard, Alice Halliday, et al.
BMC Infectious Diseases|August 21, 2025
Improving the accuracy of Respiratory Syncytial Virus (RSV) incidence estimates among hospitalised adults in Bristol, UKKatie Lihou, Robert Challen, Anastasia Chatzilena, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
Reply to Klein et al.: The importance of aerosol pH for airborne respiratory virus transmissionHenry P Oswin, Allen E Haddrell, Mara Otero-Fernandez, et al.
Pageof 24

Showing results (161-170 of 235) with videos related to

Sort By:
Pageof 24
Vaccine|December 5, 2016
Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trialMildred A Iro, Matthew D Snape, Merryn Voysey, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 18, 2017
Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedulesManish Sadarangani, Tim Sell, Mildred A Iro, et al.
Vaccine|May 10, 2017
Corrigendum to "Persistence of bactericidal antibodies following booster vaccination with 4CMenB at 12, 18 or 24months and immunogenicity of a fifth dose administered at 4years of age-a phase 3 extension to a randomised controlled trial" [Vaccine 35 (2017) 395-402]Mildred A Iro, Matthew D Snape, Merryn Voysey, et al.
Vaccine|July 14, 2020
Randomized clinical trial of DTaP5-HB-IPV-Hib vaccine administered concomitantly with meningococcal serogroup C conjugate vaccines during the primary infant seriesJennifer L Oliver, Christine Sadorge, Florence Boisnard, et al.
BMJ Open|October 23, 2020
'Be on the TEAM' Study (Teenagers Against Meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescentsJeremy Carr, Emma Plested, Parvinder Aley, et al.
The Pediatric Infectious Disease Journal|July 2, 2019
Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire StudyChristopher R Wilcox, Anna Calvert, Jane Metz, et al.
BMJ Open|May 9, 2019
B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of <i>Neisseria meningitidis</i>Helen S Marshall, Mark McMillan, Ann Koehler, et al.
Vaccine|April 5, 2024
Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trialHolly E Baum, Russell Thirard, Alice Halliday, et al.
BMC Infectious Diseases|August 21, 2025
Improving the accuracy of Respiratory Syncytial Virus (RSV) incidence estimates among hospitalised adults in Bristol, UKKatie Lihou, Robert Challen, Anastasia Chatzilena, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 29, 2022
Reply to Klein et al.: The importance of aerosol pH for airborne respiratory virus transmissionHenry P Oswin, Allen E Haddrell, Mara Otero-Fernandez, et al.
Pageof 24